About Yapanbio
Yapanbio is a company based in Hyderabad (India) founded in 2019 by Nirav Desai and Atin Tomar. Yapanbio has raised $13.4 million across 1 funding round from investors including Piramal Group and Piramal Pharma Solutions. The company has 49 employees as of April 06, 2024. Yapanbio offers products and services including Process Development, Process Characterization, and GMP Manufacturing. Yapanbio operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, VERAXA and Primrose Bio, among others.
- Headquarter Hyderabad, India
- Employees 49 as on 06 Apr, 2024
- Founders Nirav Desai, Atin Tomar
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Yapan Bio Private Limited
- Date of Incorporation 11 Oct, 2019
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$1.97 M (USD)-30.79as on Mar 31, 2023
-
Net Profit
$18.16 K (USD)-98.49as on Mar 31, 2023
-
EBITDA
$728.37 K (USD)-66.62as on Mar 31, 2023
-
Total Equity Funding
$13.4 M (USD)
in 1 rounds
-
Latest Funding Round
$13.4 M (USD), Series B
Dec 21, 2021
-
Investors
Piramal Group
& 1 more
-
Employee Count
49
as on Apr 06, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Yapanbio
Yapanbio offers a comprehensive portfolio of products and services, including Process Development, Process Characterization, and GMP Manufacturing.
Optimization and scale-up for manufacturing processes.
Establishment of models for process parameters.
Production of vaccines and biologics for studies.
People of Yapanbio
Unlock access to complete
Funding Insights of Yapanbio
Yapanbio has successfully raised a total of $13.4M through 1 strategic funding round. The most recent funding activity was a Series B round of $13.4 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Yapanbio
Yapanbio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Piramal Group and Piramal Pharma Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Serves as a contract manufacturer of pharmaceutical products for industry partners.
|
Locked | Locked | Locked | |
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
Locked | Locked | Locked |
Investor details for Yapanbio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yapanbio
Investment portfolio details for Yapanbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yapanbio
Detailed financials for Yapanbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yapanbio Comparisons
Peer comparison for Yapanbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yapanbio
Yapanbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, VERAXA and Primrose Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of Yapanbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yapanbio
Complete news archive for Yapanbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yapanbio
Yapanbio was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Yapanbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Atin Tomar is the current CEO of Yapanbio. They have also founded this company.
Yapanbio is a funded company, having raised a total of $13.4M across 1 funding round to date.
As of Apr 06, 2024, the latest employee count at Yapanbio is 49.
Annual revenue of Yapanbio is $1.97M as on Mar 31, 2023.
Yapanbio was founded in 2019 and is based in Hyderabad, India. Operations focus on the biotechnology sector, where contract manufacturing services for bio-therapeutics and vaccines are delivered. Expertise is applied in production processes to support pharmaceutical needs. Leadership includes co-founders Nirav Desai and Atin Tomar, who oversee strategic and executive functions. The company serves clients through specialized facilities in the region.
Yapanbio's top competitors include Neovacs, VERAXA and Fina Biosolutions.
Yapanbio offers Process Development, Process Characterization, and GMP Manufacturing.
Yapanbio has 2 investors. Key investors include Piramal Group, and Piramal Pharma Solutions.